Industry news

U.K. seeks to help startups by easing access to samples, data and disease models

Nick Paul Taylor / FierceBiotech

The Medicines Discovery Catapult (MDC) has detailed how it plans to help biotechs in the United Kingdom address their current pain points. Officials at the government-backed unit identified efforts to make informatics tools, preclinical models, data and samples available to startups as among the best uses of its resources.

Gilead starts a new clinical collaboration with Pfizer

GMP News

Kite, a Gilead Company, announced it has entered into a clinical trial collaboration with Pfizer, Inc. to evaluate the safety and efficacy of the investigational combination of Yescarta (axicabtagene ciloleucel) and Pfizer’s utomilumab, a fully humanized 4-1BB agonist monoclonal antibody, in patients with refractory large B-cell lymphoma.

Mandatory labeling for 7 nosologies may be introduced in 2018

GMP News

In 2020, the labeling of medicinal products will become mandatory for all manufacturers. But, for some drugs, including the expensive medicines, it may happen as early as in 2018. This was announced by Mikhail Murashko, the Head of Roszdravnadzor.

Exports of medical products will become one of the main areas for Pharma 2030

GMP News

The exports of Russian medical products will be one of the main areas of activities in the next decade, said Sergey Tsyb, the Deputy Minister of Industry and Trade of the Russian Federation.

API market will reach a value of $239.8 billion by 2025

GMP News

According to the report, recently published by Million Insights, the global Active Pharmaceutical Ingredient (API) market size was worth at USD 134.2 billion in the year 2015 which is anticipated to reach a value of $239.8 billion by 2025, with CAGR of 6.0%. Rising prevalence of chronic diseases such as neurological diseases, cardiovascular diseases, can lead to the growth.

Russian government to subsidize labeling costs of pharma producers

Remedium

The Russian government has announced that it will provide subsidies for domestic drugmakers and foreign companies operating in the local market for the partial cover their costs, associated with the forthcoming introduction of labeling procedure in the domestic pharmaceutical market, reports The Pharma Letter’s local correspondent. 

New research showed a trouble with clarity of drug approvals in Central Europe

GMP News

New research, from an international group of health policy experts led by the University of Bath (UK), reports a mixed picture of transparency in public decisions-making around new medicine approvals in Poland, one of Europe’s largest pharmaceutical markets.

Japanese pharma – no longer ‘lost in translation’

GMP News

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalisation. The CPhI Japan 2018 report – released ahead of what is likely to be the largest ever CPhI Japan (18-20 April, 2018) – has identified that demographic pressures on healthcare costs are driving a political agenda that will benefit players with lower costs solutions. 

Russian President signs the Federal Law on introduction of drug labeling

GMP News

Russian President Vladimir Putin signed the Federal Law “On amendments to the Federal law “On Circulation of medicines.” The law provides for the establishment of state information system to monitor the movement of medicinal products for human use from the manufacturer to the final consumer by using the means of identification with regard to medicinal products in order to ensure the quality control of medicinal products for human use, that are in circulation, and protect the legal trade from falsified, counterfeit, and substandard medicines.

Russia has one of the shortest periods for expert examination of medicines

GMP News

Elena Maksimkina, the Director of the Department of Drug Supply and Regulation of Medical Devices at the Russian Ministry of Health, gave her assessment of the pharmaceutical market in Russia.